Susquehanna International Group
NGNE icon

Susquehanna International Group’s Neurogene NGNE Stock Holding History

Susquehanna International Group’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$550K Buy
+27,300
New +$529K ﹤0.01% 9413
2025
Q4 		– Sell
-12,000
Closed -$208K – 13167
2025
Q3 		$208K Sell
12,000
-17,900
-60% -$359K ﹤0.01% 10913
2025
Q2 		$447K Sell
29,900
-3,100
-9% -$48.6K ﹤0.01% 9438
2025
Q1 		$386K Sell
33,000
-159,600
-83% -$2.77M ﹤0.01% 9473
2024
Q4 		$4.4M Buy
+192,600
New +$7.17M ﹤0.01% 3805
2022
Q1 		– Sell
-1,160
Closed -$112K – 13645
2021
Q4 		$112K Buy
1,160
+560
+93% +$68.2K ﹤0.01% 12060
2021
Q3 		$87K Sell
600
-2,765
-82% -$423K ﹤0.01% 12141
2021
Q2 		$621K Sell
3,365
-265
-7% -$58.6K ﹤0.01% 9046
2021
Q1 		$894K Buy
3,630
+155
+4% +$39.6K ﹤0.01% 8025
2020
Q4 		$980K Buy
3,475
+2,740
+373% +$669K ﹤0.01% 6780
2020
Q3 		$176K Sell
735
-290
-28% -$70.2K ﹤0.01% 9570
2020
Q2 		$340K Buy
1,025
+435
+74% +$113K ﹤0.01% 8138
2020
Q1 		$134K Sell
590
-1,495
-72% -$308K ﹤0.01% 9093
2019
Q4 		$514K Buy
+2,085
New +$208K ﹤0.01% 6938
2018
Q3 		– Sell
-13,865
Closed -$735K – 9903
2018
Q2 		$735K Buy
13,865
+2,995
+28% +$781K ﹤0.01% 6037
2018
Q1 		$3.06M Buy
+10,870
New +$3M ﹤0.01% 3225
2017
Q4 		– Sell
-585
Closed -$166K – 9687
2017
Q3 		$166K Buy
+585
New +$168K ﹤0.01% 8135
2017
Q2 		– Sell
-1,110
Closed -$371K – 9601
2017
Q1 		$371K Buy
+1,110
New +$390K ﹤0.01% 7017
2016
Q4 		– Sell
-940
Closed -$251K – 9939
2016
Q3 		$251K Buy
+940
New +$189K ﹤0.01% 7217

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Susquehanna International Group's NGNE Position: Q3 2025 in Review

Susquehanna International Group sold out of Neurogene (NGNE) in Q3 2025, closing a stake of 26,006 shares — an estimated $522K sold.

Susquehanna International Group first reported a position in NGNE in Q2 2016 and held it in 20 quarters. The position peaked at $6.68M in Q1 2024. 88 funds tracked by Wall St. Rank hold NGNE as of Q3 2025.

  • Susquehanna International Group reported no remaining Neurogene position as of Q3 2025 after selling out during the quarter.
  • Susquehanna International Group sold 26,006 Neurogene shares in Q3 2025, an estimated $522K.
  • Susquehanna International Group first reported a position in Neurogene in Q2 2016 and held it in 20 quarters.
  • Susquehanna International Group's Neurogene position peaked at $6.68M in Q1 2024.
  • 88 funds tracked by Wall St. Rank held Neurogene as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.